Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.

Heidi Fiegl; Allison Jones; Cornelia Hauser-Kronberger; Georg Hutarew; Roland Reitsamer; Robin L Jones; Mitch Dowsett; Elisabeth Mueller-Holzner; Gudrun Windbichler; Günter Daxenbichler; Georg Goebel; Christian Ensinger; Ian Jacobs; Martin Widschwendter

doi:10.1158/1078-0432.CCR-07-4557

Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.

Heidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger (Co-author), Georg Hutarew (Co-author), Roland Reitsamer (Co-author), Robin L Jones, Mitch Dowsett, Elisabeth Mueller-Holzner, Gudrun Windbichler, Günter Daxenbichler, Georg Goebel, Christian Ensinger, Ian Jacobs, Martin Widschwendter

Research output: Contribution to journal › Original Article › peer-review

34 Citations (Web of Science)

Original language	English
Pages (from-to)	3494-3502
Journal	CLINICAL CANCER RESEARCH
Volume	14
Issue number	11
DOIs	https://doi.org/10.1158/1078-0432.CCR-07-4557
Publication status	Published - 2008

Keywords

EMBRYONIC STEM-CELLS
NEOADJUVANT CHEMOTHERAPY
PROGNOSTIC-SIGNIFICANCE
PATHOLOGICAL RESPONSE
PHASE-II
EXPRESSION
TUMOR
THERAPY
TISSUE
CYCLOOXYGENASE-2

Access to Document

10.1158/1078-0432.CCR-07-4557

Cite this

Fiegl, H., Jones, A., Hauser-Kronberger, C., Hutarew, G., Reitsamer, R., Jones, R. L., Dowsett, M., Mueller-Holzner, E., Windbichler, G., Daxenbichler, G., Goebel, G., Ensinger, C., Jacobs, I., & Widschwendter, M. (2008). Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. CLINICAL CANCER RESEARCH , 14(11), 3494-3502. https://doi.org/10.1158/1078-0432.CCR-07-4557

Fiegl, Heidi ; Jones, Allison ; Hauser-Kronberger, Cornelia et al. / Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. In: CLINICAL CANCER RESEARCH 2008 ; Vol. 14, No. 11. pp. 3494-3502.

@article{5eab354475484e4493a6892cc7a38c22,

title = "Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.",

keywords = "EMBRYONIC STEM-CELLS, NEOADJUVANT CHEMOTHERAPY, PROGNOSTIC-SIGNIFICANCE, PATHOLOGICAL RESPONSE, PHASE-II, EXPRESSION, TUMOR, THERAPY, TISSUE, CYCLOOXYGENASE-2",

author = "Heidi Fiegl and Allison Jones and Cornelia Hauser-Kronberger and Georg Hutarew and Roland Reitsamer and Jones, {Robin L} and Mitch Dowsett and Elisabeth Mueller-Holzner and Gudrun Windbichler and G{\"u}nter Daxenbichler and Georg Goebel and Christian Ensinger and Ian Jacobs and Martin Widschwendter",

year = "2008",

doi = "10.1158/1078-0432.CCR-07-4557",

language = "English",

volume = "14",

pages = "3494--3502",

journal = "CLINICAL CANCER RESEARCH ",

issn = "1078-0432",

publisher = "Amer Assoc Cancer Research",

number = "11",

}

Fiegl, H, Jones, A, Hauser-Kronberger, C, Hutarew, G , Reitsamer, R, Jones, RL, Dowsett, M, Mueller-Holzner, E, Windbichler, G, Daxenbichler, G, Goebel, G, Ensinger, C, Jacobs, I & Widschwendter, M 2008, 'Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.', CLINICAL CANCER RESEARCH , vol. 14, no. 11, pp. 3494-3502. https://doi.org/10.1158/1078-0432.CCR-07-4557

Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. / Fiegl, Heidi; Jones, Allison; Hauser-Kronberger, Cornelia (Co-author) et al.
In: CLINICAL CANCER RESEARCH , Vol. 14, No. 11, 2008, p. 3494-3502.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.

AU - Fiegl, Heidi

AU - Jones, Allison

AU - Hauser-Kronberger, Cornelia

AU - Hutarew, Georg

AU - Reitsamer, Roland

AU - Jones, Robin L

AU - Dowsett, Mitch

AU - Mueller-Holzner, Elisabeth

AU - Windbichler, Gudrun

AU - Daxenbichler, Günter

AU - Goebel, Georg

AU - Ensinger, Christian

AU - Jacobs, Ian

AU - Widschwendter, Martin

PY - 2008

Y1 - 2008

KW - EMBRYONIC STEM-CELLS

KW - NEOADJUVANT CHEMOTHERAPY

KW - PROGNOSTIC-SIGNIFICANCE

KW - PATHOLOGICAL RESPONSE

KW - PHASE-II

KW - EXPRESSION

KW - TUMOR

KW - THERAPY

KW - TISSUE

KW - CYCLOOXYGENASE-2

U2 - 10.1158/1078-0432.CCR-07-4557

DO - 10.1158/1078-0432.CCR-07-4557

M3 - Original Article

C2 - 18519782

SN - 1078-0432

VL - 14

SP - 3494

EP - 3502

JO - CLINICAL CANCER RESEARCH

JF - CLINICAL CANCER RESEARCH

IS - 11

ER -

Fiegl H, Jones A, Hauser-Kronberger C, Hutarew G , Reitsamer R, Jones RL et al. Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. CLINICAL CANCER RESEARCH . 2008;14(11):3494-3502. doi: 10.1158/1078-0432.CCR-07-4557